2 studies found for:    9488617 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Antithymocyte globulin;   Drug: Cyclosporine
2 Completed A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
Intervention: Drug: Daclizumab

Indicates status has not been verified in more than two years